Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,181.00    -15.50 (-1.30%)
Bid:
1,180.00
Ask:
1,181.50
Spread: 1.50 (0.127%)
Market Cap: £6.01b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Share buy-back programme

2 Mar 2026 07:00

RNS Number : 7470U
St. James's Place PLC
02 March 2026
 

St. James's Place plc

 

Share buy-back programme

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

Further to the announcement made on 25 February 2026, St. James's Place plc (the Company) announces that it is commencing a share buy-back programme to repurchase its ordinary shares, subject to a maximum consideration of £122.6 million. The programme will begin on 2 March 2026 and end no later than 31 August 2026. The sole purpose of the buy-back programme is to reduce the capital of the Company.

 

The programme will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc is (Morgan Stanley), pursuant to which Morgan Stanley shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company in accordance with the Company's current buy-back authority granted by shareholders. Morgan Stanley will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company (including, for the avoidance of doubt, in the case of any purchases made during closed periods).

 

Any purchase of ordinary shares done in relation to this announcement will be carried out on the London Stock Exchange and Multilateral Trading Facilities, as defined by the Directive 2014/65/EU on markets in financial instruments (including the delegated and implementing acts adopted under it) as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter, and executed in accordance with the Listing Rules and the company's general authority to make market purchases of shares. The shares will be purchased in accordance with the price and volume conditions set out in the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter. The company will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. To the extent permitted by law, ordinary shares purchased under the programme will be cancelled.

 

 

Enquiries:

Hugh Taylor, Director - Investor Relations

Tel: 07818 075143

Angela Warburton, Director - Communications

Tel: 07442 479542

 

Brunswick Group:

 

Tel: 020 7404 5959

Eilis Murphy

 

Email: sjp@brunswickgroup.com  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKOBPKBKDABB
Date   Source Headline
13th Oct 20237:00 amRNSResponse to Media Speculation
2nd Oct 202311:04 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 20237:04 amRNSCEO Succession
1st Sep 20231:10 pmRNSTotal Voting Rights
22nd Aug 20239:43 amRNSHolding(s) in Company
11th Aug 20234:30 pmRNSHolding(s) in Company
1st Aug 202311:40 amRNSBlock listing Interim Review
1st Aug 202310:44 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSHalf-year Report
3rd Jul 20239:58 amRNSTotal Voting Rights
27th Jun 20233:04 pmRNSHolding(s) in Company
2nd Jun 20232:53 pmRNSDirector/PDMR Shareholding
1st Jun 20239:13 amRNSTotal Voting Rights
23rd May 20232:59 pmRNSDirector/PDMR Shareholding
18th May 20231:20 pmRNSResult of AGM
4th May 20232:17 pmRNSDirector/PDMR Shareholding
3rd May 202310:22 amRNSDirector/PDMR Shareholding
2nd May 202311:11 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSQ1 New Business Inflows and Funds Under Management
11th Apr 202311:04 amRNSNotice of AGM
3rd Apr 202311:00 amRNSTotal Voting Rights
31st Mar 20239:57 amRNSDirector/PDMR Shareholding
29th Mar 202312:51 pmRNSDirector/PDMR Shareholding
27th Mar 202311:15 amRNSDirector/PDMR Shareholding
22nd Mar 202311:43 amRNSAdditional Listing
22nd Mar 202311:18 amRNSDirector/PDMR Shareholding
7th Mar 202312:17 pmRNSAnnual Report and Accounts 2022
1st Mar 202311:02 amRNSTotal Voting Rights
28th Feb 20237:00 amRNSFinal Results
1st Feb 202311:50 amRNSTotal Voting Rights
1st Feb 202311:12 amRNSBlock listing Interim Review
26th Jan 20237:00 amRNS2022 New Business Inflows & Funds Under Management
3rd Jan 202312:06 pmRNSTotal Voting Rights
30th Dec 202211:55 amRNSHolding(s) in Company
19th Dec 20224:34 pmRNSHolding(s) in Company
12th Dec 20224:16 pmRNSHolding(s) in Company
1st Dec 202210:21 amRNSTotal Voting Rights
21st Nov 20224:45 pmRNSDirector/PDMR Shareholding
1st Nov 20229:34 amRNSTotal Voting Rights
28th Oct 20221:03 pmRNSDirectorate Change
26th Oct 202211:21 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSQ3 New Business Inflows and Funds Under Management
19th Oct 20223:56 pmRNSDirector/PDMR Shareholding
17th Oct 20225:02 pmRNSHolding(s) in Company
3rd Oct 202210:20 amRNSTotal Voting Rights
29th Sep 202211:09 amRNSDirector/PDMR Shareholding
15th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:08 pmRNSTotal Voting Rights
1st Aug 20223:44 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.